Resistell News:

Resistell among 10 promising European medtech startups to watch in 2020

newsimage
newsimage
Resistell News:

Resistell among 10 promising European medtech startups to watch in 2020

As medical developments zoom ahead, it’s increasingly the startups that are leading the charge. From young teams springing out of Europe’s best medical universities, to entrepreneurs twinning up with expert clinical practitioners who have found a problem to solve, there is no shortage of European medtech startups that are revolutionizing healthcare.
curves

Latest news

news image news image
6th June 2018

Resistell qualifies as a finalist of MassChallenge Switzerland 2018

Last week, we competed with over 200 startups from 31 countries in final judging round at Campus Biotech in Geneva. We are pleased to inform that Resistell AG qualified to the finals!
news image news image
4th June 2018

31.05.2018 - Resistell the winner of Venture Kick stage 2

31.05.2018 - Resistell's team has won the Venture Kick stage 2!
1st June 2018

Antibiotic resistance crisis worsening because of collapse in supply

The Access To Medicine foundation warns that antibiotic supply chain issues are helping to fuel the rise in AMR Their solution? ‘The right products need to reach the right patients at the right time’ - exactly what Resistell is working toward.
24th May 2018

The Antibiotics Problem

Discover how the search for a rapid diagnostic system lies at the heart of tackling antibiotic resistance, a problem which is predicted to kill 10 million people a year by 2050. Resistell is working to create the innovative solutions needed.
news image news image
20th April 2018

Containing Unusual Resistance

The Centers for Disease Control and Prevention (CDC) have outlined the ways in which health departments can prevent the spread of antibiotic resistance. Rapid identification of resistant bacteria is at the heart of their strategy. Resistell is helping to make that a reality.
news image news image
18th April 2018

New mechanism of drug resistance discovered in Pseudomonas aeruginosa

Bacteria such as Pseudomonas aeruginosa are becoming resistant to the widely used antibiotic Ciprofloxacin (CIP). As resistance like this spreads the pioneering work of Resistell becomes more urgent. See how we’re leading the search for faster and more accurate diagnosis.
news image news image
10th April 2018

#sciencenews #antibiotics #CDC #gonorrhea #drugresistance #publichealth

First case of super-resistant gonorrhea reported⚠️ The emergence of a strain of ‘super-gonorrhoea’, resistant to existing antibiotics, means that a global medical crisis is closer to becoming a reality. @Resistell are utilising the latest technology to create the speed and accuracy needed to fight back against that crisis.